Abstract
We investigated the expression of the PLZF gene in purified human hematopoietic progenitors induced to unilineage erythroid, granulocytic or megakaryocytic differentiation and maturation in serum-free culture. PLZF is expressed in quiescent progenitors: the expression level progressively rises through megakaryocytic development, whereas it gradually declines in erythroid and granulopoietic culture. To investigate the role of PLZF in megakaryopoiesis, we transduced the PLZF gene into the erythro-megakaryocytic TF1 cell line. PLZF overexpression upmodulates the megakaryocytic specific markers (CD42a, CD42b, CD61, PF4) and induces the thrombopoietin receptor (TpoR). The proximal promoter of the TpoR gene is activated in PLZF-expressing TF1 cells: in this promoter region, a PLZF DNA-binding site was identified by deletion constructs studies. Interestingly, PLZF and GATA1 proteins coimmunoprecipitate in PLZF-expressing TF1 cells: enforced expression of both PLZF and GATA1 in TF1 cells results in increased upregulation of megakaryocytic markers, as compared to exogenous PLZF or GATA1 alone, suggesting a functional role for the PLZF/GATA1 complex. Our data indicate that PLZF plays a significant stimulatory role in megakaryocytic development, seemingly mediated in part by induction of TpoR expression at transcriptional level. This stimulatory effect is potentiated by physical interaction of PLZF and GATA1, which are possibly assembled in a multiprotein transcriptional complex.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Albagli O, Lantoine D, Quief S, Quignon F, Englert C, Kerckaert JP, Montarras D, Pinset C, Lindon C . 1999 Oncogene 18: 5063–5075
Ahmad KF, Engel CK, Prive GG . 1998 Proc. Natl. Acad. Sci USA 95: 12123–12128
Ball H, Melnick A, Shaknovich R, Kohanski R, Licht JD . 1999 Nucleic Acids Res. 27: 4106–4113
Bardwell VJ, Treisman R . 1994 Genes Dev. 8: 1664–1677
Barna M, Hawe N, Niswander L, Pandolfi PP . 2000 Nature Genetics 25: 166–172
Chen SJ, Zelent A, Tong JH, Yu HO, Wang ZY, Derre J, Berger R, Waxman S, Chen Z . 1993a J. Clin. Invest. 91: 2260–2267
Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY, Waxman S, Zelent A . 1993b EMBO J. 12: 1161–1167
Chen ZX, Xue Y, Zhang R, Tao R, Xia X, Li C, Wang W, Zu W, Yao X, Ling B . 1991 Blood 78: 1413–1419
Condorelli GL, Tocci A, Botta R, Facchiano F, Testa U, Vitelli L, Valtieri M, Croce CM, Peschle C . 1997 Mol. Cell. Biol. 17: 2954–2969
Cook M, Gould A, Brand N, Davies J, Strutt P, Shaknovich R, Licht J, Waxman S, Chen Z, Gluecksohn-Waelsch S, Krumlauf R, Zelent A . 1995 Proc. Natl. Acad. Sci. USA 92: 2249–2253
David G, Alland L, Hong SH, Wong CW, DePinho RA, Dejean A . 1998 Oncogene 16: 2549–2556
Davies JM, Hawa N, Kabarowski J, Huang QH, Zhu J, Brand NJ, Leprince D, Dhordain P, Cook M, Morris-Kay G, Zelent A . 1999 Oncogene 18: 365–375
Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Romeo PH, Mignotte V . 1996 Blood 87: 4678–4685
Dhordain P, Albagli O, Honore N, Guidez F, Lantoine D, Schmid M, De The H, Zelent A, Koken MHM . 2000 Oncogene 19: 6240–6250
Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong HJ, Wang ZY, Licht J, Waxman S, Chomienne C, Chen Z, Zelent A, Chen SJ . 1996 Proc. Natl. Acad. Sci. USA 93: 3624–3629
Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peschle C . 1990 Science 249: 1561–1564
Godin IE, Garcia-Porrero JA, Coutinho A, Dieterlen-Lievre F, Marcos MA . 1993 Nature 364: 67–70
Gregory RC, Taxman DJ, Seshasayee D, Kensinger MH, Bieker JJ, Wojchowski DM . 1996 Blood 87: 1763–1801
Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pellici PG . 1998a Nature 391: 815–818
Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Grignani F, Lanfrancone L, Peschle C, Nolan GP, Pelicci PG . 1998b Cancer Res. 58: 14–19
Guerriero R, Testa U, Gabbianelli M, Mattia G, Montesoro E, Macioce G, Pace A, Ziegler B, Hassan HJ, Peschle C . 1995 Blood 86: 3725–3736
Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A . 1998 Blood 91: 2634–2642
Hawe N, Soares V, Niswander L, Cattoretti G, Pandolfi P . 1996 Blood 88: 291a, p 1151 (abstr, supp 1)
He LZ, Guidez F, Tribioli C, et Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP . 1998 Nat. Genet. 18: 126–135
Hoatlin ME, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A, Licht JD . 1999 Blood 94: 3737–3747
Hong SH, David G, Wong CW, Dejean A, Privalsky ML . 1997 Proc. Natl. Acad. Sci. USA 94: 9028–9033
Hung HL, Lau J, Kim AY, Weiss MJ, Blobel GA . 1999 Mol. Cell. Biol. 19: 3496–3505
Ivins S, Zelent A . 1998 Blood 92: 308a (abstr, suppl 1)
Koken MH, Reid A, Quignon F, Chelbi-Alix MK, Davies JM, Kabarowski JH, Zhu J, Dong S, Chen S, Chen Z, Tan CC, Licht J, Waxman S, de The H, Zelent A . 1997 Proc. Natl. Acad. Sci. USA 94: 10255–10260
Kotani H, Newton PB, Zhang S, Chiang YL, Otto E, Weaver L, Blaese RM, Anderson WF, McGarrity GJ . 1994 Hum. Gene Ther. 5: 19–28
Labbaye C, Valtieri M, Barberi T, Meccia E, Masella B, Pelosi E, Condorelli GL, Testa U, Peschle C . 1995 J. Clin. Invest. 95: 2346–2358
Labbaye C, Valtieri M, Grignani F, Puglisi R, Luchetti L, Masella B, Alcalay M, Testa U, Peschle C . 1999 Oncogene 18: 3529–3540
Li JY, English MA, Ball HJ, Yeyati PL, Waxman S, Licht JD . 1997 J. Biol. Chem. 272: 22447–22455
Long JJ, Leresche A, Kriwacki RW, Gottesfeld JM . 1998 Mol. Cell. Biol. 18: 1467–1476
Maouche L, Tournamille C, Hattab C, Boffa G, Cartron JP, Chretien S . 1991 Blood 78: 2557–2563
Medvinsky AL, Samoylina NL, Muller AM, Dzierzak EA . 1993 Nature 364: 64–67
Melnick A, Licht JD . 1999 Blood 93: 3167–3215
Merika M, Orkin SH . 1995 Mol. Cell. Biol. 15: 2437–2447
Mignotte V, Vignon I, Boucher de Crevecoeur E, Romeo PH, Lemarchandel V, Chretien S . 1994 Genomics 20: 1 5–12
Orkin SH . 1992 Blood 80: 575–581
Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V, Orkin SH, Costantini F . 1991 Nature 349: 257–260
Ravid K, Doi T, Beeler DL, Kuter DJ, Rosenberg RD . 1991 Mol. Cell. Biol. 11: 6116–6127
Reid A, Gould A, Brand N, Cook M, Strutt P, Li J, Licht J, Waxman S, Krumlauf R, Zelent A . 1995 Blood 86: 4544–4552
Shaknovich R, Yeyati PL, Ivins S, Melnick A, Lempert C, Waxman S, Zelent A, Licht JD . 1998 Mol. Cell. Biol. 18: 5533–5545
Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH . 1997 EMBO J. 16: 3965–3973
Tabilio A, Rosa JP, Testa U, Kieffer N, Nurden AT, Del Canizo MC, Breton-Gorius J, Vainchenker W . 1984 EMBO J. 3: 453–459
Takahashi S, Romeno T, Suwabe N, Yoh K, Nakajima O, Nishimura S, Kuroha T, Nagasawa T, Yamamoto M . 1998 Blood 92: 434–442
Testa U, Fossati C, Samoggia P, Masciulli R, Mariani G, Hassan HJ, Sposi NM, Guerriero R, Rosato V, Gabbianelli M, Pelosi E, Valtieri M, Peschle C . 1996 Blood 88: 3391–3406
Tsang AH, Neufeld TP, Kvan E, Rubin GM . 1997 Cell 90: 459–467
Valtieri M, Schiro R, Chelucci C, Masella B, Testa U, Casella I, Montesoro E, Mariani G, Hassan HJ, Peschle C . 1994 Cancer Res. 54: 4398–4404
Vignon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M . 1992 Proc. Natl. Acad. Sci. USA 89: 5640–5644
Vyas P, Ault K, Jackson CW, Orkin SH, Shivdasani RA . 1999 Blood 93: 2867–2875
Wadman IA, Osada H, Grutz GG, Agulnick AD, Westphal H, Forster A, Rabbitts TH . 1997 EMBO J. 16: 3145–3157
Ward JO, McConnell MJ, Carlile GW, Pandolfi PP, Licht JD, Freedman LP . 2001 Blood 98: 3290–3300
Wong CW, Privalsky ML . 1998 J. Biol. Chem. 273: 27695–27702
Yamaguchi Y, Zon LI, Ackerman SJ, Yamamoto M, Suda T . 1998 Blood 91: 450–457
Yang E, Korsmeyer SJ . 1996 Blood 88: 386–401
Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S, Nason-Burchenal K, Dmitrovsky E, Zelent A, Licht JD . 1999 Oncogene 18: 925–934
Zhang P, Behre G, Pan J, Iwana A, Wara-Aswapati N, Radomska HS, Auron PE, Tenen DG . 1999a Proc. Natl. Acad. Sci. USA 96: 8705–8710
Zhang T, Xiong H, Kan LX, Zhang CK, Jiao XF, Fu G, Zhang QH, Lu L, Tong JH, Gu BW, Yu M, Liu JX, Licht J, Waxman S, Zelent A, Chen E, Chen SJ . 1999b Proc. Natl. Acad. Sci. USA 96: 11422–11427
Zimmet J, Ravid K . 2000 Exp. Hematol. 28: 3–16
Acknowledgements
We thank M Blasi and M Fontana for editorial assistance and A Zito and G Loreto for graphics. This work was partially supported by NIH grant CA 59936 to JD Licht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Labbaye, C., Quaranta, M., Pagliuca, A. et al. PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene 21, 6669–6679 (2002). https://doi.org/10.1038/sj.onc.1205884
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205884
Keywords
This article is cited by
-
SCL/TAL1-mediated Transcriptional Network Enhances Megakaryocytic Specification of Human Embryonic Stem Cells
Molecular Therapy (2015)
-
Analysis of the interaction between Zinc finger protein 179 (Znf179) and promyelocytic leukemia zinc finger (Plzf)
Journal of Biomedical Science (2013)
-
PLZF-mediated control on c-kit expression in CD34+ cells and early erythropoiesis
Oncogene (2009)
-
A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis
Nature Cell Biology (2008)
-
Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4
Journal of Molecular Medicine (2008)